Question follow-through · 15261
NHS: Staff
To ask the Minister for the Cabinet Office, whether the prohibition of two-tier workforce regulations will be applied to all NHS- funded outsourced contracts since 4 July 2024; and whether he has asked NHS England to provide guidance to NHS organisations.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Cabinet Office
- Tabled
- 20 Nov 2024
- Target answer date
- 27 Nov 2024
- Answer
- 27 Nov 2024 · 7 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
20 Nov 2024
Question tabled
To ask the Minister for the Cabinet Office, whether the prohibition of two-tier workforce regulations will be applied to all NHS- funded outsourced contracts since 4 July 2024; and whether he has asked NHS England to provide guidance to NHS organisations.
27 Nov 2024
Target answer date
Date supplied by the official written-questions record.
27 Nov 2024
Answer published
The Employment Rights Bill, once in force, will provide powers to make regulations to introduce provisions for new protections for transferring workers in relevant outsourcing contracts. The provisions will apply to contracting authorities as defined in t...
Official data retrieved 27 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
No later same-department questions indexed.
This is an absence in covered public data, not evidence that no follow-up occurred elsewhere.